Pharmacovigilance of triazole antifungal agents: Analysis of the FDA adverse event reporting system (FAERS) database

Pharmacovigilance of triazole antifungal agents: Analysis of the FDA adverse event reporting system (FAERS) database

Triazole antifungal drugs (TAD) are widely used to treat invasive fungal infections due to their broad antifungal spectrum and low toxicity. Despite their preference in the clinic, multiple Adverse Events (AE) are still reported each year. Objective: We aimed to characterize the distribution of Adve...

Full description

Bibliographic Details
Main Authors: Jianxing Zhou, Zipeng Wei, Baohua Xu, Maobai Liu, Ruichao Xu, Xuemei Wu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Pharmacology
Subjects:
triazole antifungal agents
pharmacovigilance
adverse events
information component
spectrum
isavuconazole (DRUG)
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.1039867/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.1039867/full

Similar Items